Lost in the Labyrinth: Predicting Central Neurological Causes of Vertigo Dizziness and Unsteadiness in the Emergency Department. A Multicentre Cross-sectional Observational Study (VERTIGO)

December 4, 2025 updated by: Marco Bonzano, Fondazione IRCCS Policlinico San Matteo di Pavia
This study will assess the sensitivity and specificity of the bedside examination algorithm performed by ED physicians. Finally, it aims to identify predictors of a central cause of the symptoms. This will consequently reduce the rate of misdiagnosis as well as the costs and length of stay due to inappropriate neuroimaging.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

825

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pavia
      • Pavia, Pavia, Italy, 27100
        • Recruiting
        • SC Pronto Soccorso e Medicina d'Urgenza, Fondazione IRCCS Policlinico San Matteo
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients presenting at the ED with vertigo, dizziness or unsteadiness

Description

Inclusion Criteria:

  • Patients presenting at the ED with vertigo, dizziness or unsteadiness
  • >= 18 years of age
  • Patients able to give their consent

Exclusion Criteria:

  • Patients with dementia
  • Bedridden patients (for causes other than the current symptoms)
  • Patients with obvious neurological findings presenting with vertigo but with suspected stroke at triage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients presenting at the ED with vertigo, dizziness, and unsteadiness
Patients presenting to the ED with vertigo/ dizziness
ED visit comprehensive of bedside examination of vertigo performed by trained EP or emergency medicine residents

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The AUC of the bedside examination algorithm performed by ED physicians
Time Frame: up to 36 months
up to 36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
identification of predictors of true positive patients
Time Frame: up to 36 months
Predictors of true positive patients can help to stratify patients with vertigo for the risk of stroke.
up to 36 months
evaluation of number of neuroimaging tests (TC and angio-TC) performed to patients with vertigo in the ED.tests performed
Time Frame: up to 36 months
to study the use of ED resources for these patients in terms of number of neuroimaging tests performed.
up to 36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2024

Primary Completion (Estimated)

February 26, 2027

Study Completion (Estimated)

February 26, 2027

Study Registration Dates

First Submitted

December 4, 2025

First Submitted That Met QC Criteria

December 4, 2025

First Posted (Actual)

December 17, 2025

Study Record Updates

Last Update Posted (Actual)

December 17, 2025

Last Update Submitted That Met QC Criteria

December 4, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dizziness

Clinical Trials on Bedside examination of Vertigo

Subscribe